Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2002-5-13
pubmed:abstractText
This study determined the effect of different weekly dosing schedules of 5-fluorouracil (5-FU)/leucovorin (LV)/eniluracil on dihydropyrimidine dehydrogenase (DPD) activity and plasma uracil levels.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1078-0432
pubmed:author
pubmed:issnType
Print
pubmed:volume
8
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1045-50
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12006517-Administration, Oral, pubmed-meshheading:12006517-Adult, pubmed-meshheading:12006517-Aged, pubmed-meshheading:12006517-Aged, 80 and over, pubmed-meshheading:12006517-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:12006517-Dihydrouracil Dehydrogenase (NADP), pubmed-meshheading:12006517-Drug Administration Schedule, pubmed-meshheading:12006517-Female, pubmed-meshheading:12006517-Fluorouracil, pubmed-meshheading:12006517-Humans, pubmed-meshheading:12006517-Leucovorin, pubmed-meshheading:12006517-Leukocytes, Mononuclear, pubmed-meshheading:12006517-Male, pubmed-meshheading:12006517-Middle Aged, pubmed-meshheading:12006517-Neoplasms, pubmed-meshheading:12006517-Oxidoreductases, pubmed-meshheading:12006517-Time Factors, pubmed-meshheading:12006517-Uracil
pubmed:year
2002
pubmed:articleTitle
Impact of two weekly schedules of oral eniluracil given with fluorouracil and leucovorin on the duration of dihydropyrimidine dehydrogenase inhibition.
pubmed:affiliation
National Cancer Institute-Navy Medical Oncology, Cancer Therapeutics Branch, Center for Cancer Research, National Naval Medical Center, Bethesda, Maryland 20889-5105, USA.
pubmed:publicationType
Journal Article, Clinical Trial